Health
Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting – News-Medical.Net
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance…
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th…
Continue Reading
-
General24 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General21 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News22 hours agoAlleged Gold Coast conman exposed: elderly woman’s life savings vanish in shocking scam
-
Noosa News22 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW